Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Massachusetts General Hospital
St. Jude Children's Research Hospital
Fred Hutchinson Cancer Center
Ossium Health, Inc.
Children's Hospital Medical Center, Cincinnati
M.D. Anderson Cancer Center
Center for International Blood and Marrow Transplant Research
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Center for International Blood and Marrow Transplant Research
Wake Forest University Health Sciences
Mayo Clinic